Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Linaprazan glurate by Cinclus Pharma Holding for Reflux Esophagitis (Gastroesophageal Reflux Disease): Likelihood of Approval
Linaprazan glurate is under clinical development by Cinclus Pharma Holding and currently in Phase II for Reflux Esophagitis (Gastroesophageal Reflux...